House McKinsey Probe Eyes Risk Process Once Led by Fed’s Barkin

The report, issued by the committee’s Democratic majority, identified what it called “significant conflicts of interest” at the consulting firm. It found at least 22 McKinsey consultants, including senior partners, had worked for the Food and Drug Administration, which oversees the pharmaceuticals industry, and for opioid manufacturers, sometimes at the same time.


Leave a Comment